Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$879M |
| 2 |
Bank of America
BAC
|
+$352M |
| 3 |
Intel
INTC
|
+$243M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$232M |
| 5 |
AB InBev
BUD
|
+$188M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.82B |
| 2 |
Amazon
AMZN
|
+$884M |
| 3 |
Air Products & Chemicals
APD
|
+$219M |
| 4 |
Mondelez International
MDLZ
|
+$198M |
| 5 |
WFT
Weatherford International plc
WFT
|
+$181M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.22% |
| 2 | Technology | 1.15% |
| 3 | Consumer Discretionary | 1.1% |
| 4 | Financials | 1.05% |
| 5 | Communication Services | 0.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
CALL
JB Hunt Transport Services
JBHT
$24.8B
| $8.23M | ﹤0.01% |
89,700
+40,100
| +81% | +$3.89M |
|
|
NVRO
1802
CALL
DELISTED
NEVRO CORP.
NVRO
| $8.23M | ﹤0.01% |
87,800
-37,100
| -30% | -$3.36M |
|
1803
Tenaris
TS
$27.2B
| $8.23M | ﹤0.01% |
+240,956
| New | +$8.2M |
|
|
FISV
1804
CALL
Fiserv Inc
FISV
$27.9B
| $8.22M | ﹤0.01% |
142,600
+54,800
| +62% | +$3.08M |
|
|
ESV
1805
PUT
DELISTED
Ensco Rowan plc
ESV
| $8.22M | ﹤0.01% |
229,600
-33,200
| -13% | -$1.35M |
|
1806
PUT
iShares MSCI Spain ETF
EWP
$2.26B
| $8.22M | ﹤0.01% |
270,200
+230,700
| +584% | +$6.47M |
|
1807
PUT
H&R Block
HRB
$6.49B
| $8.22M | ﹤0.01% |
353,400
+218,600
| +162% | +$4.89M |
|
1808
PUT
Exelon
EXC
$45.8B
| $8.21M | ﹤0.01% |
320,077
-943,966
| -75% | -$24.1M |
|
1809
CALL
SFL Corp
SFL
$1.6B
| $8.21M | ﹤0.01% |
558,600
-60,500
| -10% | -$900K |
|
|
ESPR
1810
CALL
DELISTED
Esperion Therapeutics
ESPR
| $8.2M | ﹤0.01% |
232,300
+175,100
| +306% | +$4.01M |
|
|
QVCGA
1811
CALL
DELISTED
QVC Group Inc Series A
QVCGA
| $8.2M | ﹤0.01% |
8,438
+4,594
| +120% | +$4.32M |
|
1812
The GEO Group
GEO
$4.31B
| $8.19M | ﹤0.01% |
264,774
-161,934
| -38% | -$4.66M |
|
1813
PUT
ArcelorMittal
MT
$56.2B
| $8.18M | ﹤0.01% |
326,700
-246,600
| -43% | -$6.24M |
|
|
SIVB
1814
CALL
DELISTED
SVB Financial Group
SIVB
| $8.17M | ﹤0.01% |
43,900
-68,900
| -61% | -$12.5M |
|
1815
Annaly Capital Management
NLY
$17.2B
| $8.16M | ﹤0.01% |
183,703
-113,075
| -38% | -$4.81M |
|
|
AVXS
1816
CALL
DELISTED
AveXis, Inc. Common Stock
AVXS
| $8.15M | ﹤0.01% |
107,200
+91,200
| +570% | +$5.64M |
|
1817
CALL
Criteo S.A.
CRTO
$831M
| $8.14M | ﹤0.01% |
162,800
+7,100
| +5% | +$332K |
|
|
GNC
1818
PUT
DELISTED
GNC Holdings, Inc.
GNC
| $8.13M | ﹤0.01% |
1,105,000
+549,400
| +99% | +$4.73M |
|
1819
Lincoln National
LNC
$8.29B
| $8.13M | ﹤0.01% |
124,196
+39,996
| +48% | +$2.73M |
|
1820
XPO
XPO
$22.5B
| $8.11M | ﹤0.01% |
489,814
+475,730
| +3,378% | +$7.77M |
|
|
CA
1821
CALL
DELISTED
CA, Inc.
CA
| $8.11M | ﹤0.01% |
255,700
-68,200
| -21% | -$2.19M |
|
1822
CALL
DexCom
DXCM
$33.6B
| $8.11M | ﹤0.01% |
382,800
+87,600
| +30% | +$1.71M |
|
1823
PUT
Neurocrine Biosciences
NBIX
$15.9B
| $8.1M | ﹤0.01% |
187,000
+71,900
| +62% | +$3.08M |
|
1824
Autoliv
ALV
$9.05B
| $8.07M | ﹤0.01% |
109,571
-51,123
| -32% | -$3.96M |
|
1825
Intuit
INTU
$94.6B
| $8.07M | ﹤0.01% |
69,597
-24,857
| -26% | -$2.98M |
|
Similar funds
Jeff Yass's Q1 2017 Portfolio in Review
As of Q1 2017, Jeff Yass held 10,995 positions worth $198B, up 0.36% from $197B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Jeff Yass withdrew a net $13.1B in Q1 2017, closing 2,170 positions and reducing 3,725 holdings. Its most notable exit was Air Products & Chemicals, an estimated $219M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 1.2% of assets, down from 1.2% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Jeff Yass opened a new position in iShares MSCI EAFE ETF worth $131M.
- Jeff Yass's largest Q1 2017 buy was iShares MSCI EAFE ETF: 2,100,985 shares worth $131M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2017, an estimated $879M increase.
- Jeff Yass's biggest Q1 2017 reduction was Apple, cutting an estimated $1.82B.
- Jeff Yass fully exited Air Products & Chemicals in Q1 2017, selling an estimated $219M.
- Jeff Yass's ten largest holdings make up 22% of its $198B portfolio in Q1 2017.
- Jeff Yass opened 1,488 new positions and closed 2,170 in Q1 2017.
- Jeff Yass's portfolio value rose 0.36% quarter-over-quarter to $198B.
Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.